Guidelines for the diagnosis and treatment of primary aldosteronism—the Japan Endocrine Society 2009

  • Nishikawa Tetsuo
    Department of Medicine, Yokohama Rosai Hospital, Yokohama, Japan The Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society
  • Omura Masao
    Endocrinology & Diabetes Center, Yokohama Rosai Hospital, Yokohama, Japan The Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society
  • Satoh Fumitoshi
    Division of Nephrology, Endocrinology and Vascular Medicine, Tohoku University Hospital, Sendai, Japan The Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society
  • Shibata Hirotaka
    Department of Internal Medicine, School of Medicine, Keio University, Tokyo, Japan The Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society
  • Takahashi Katsutoshi
    Department of Nephrology and Endocrinology, University of Tokyo, Graduate School of Medicine, Tokyo, Japan The Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society
  • Tamura Naohisa
    Department of Endocrinology and Diabetes, Koseikai Takeda Hospital, Kyoto, Japan The Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society
  • Tanabe Akiyo
    Department of Medicine, Institute of Clinical Endocrinology and Hypertension, Tokyo Women’s Medical University, Tokyo, Japan The Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society

書誌事項

タイトル別名
  • Guidelines for the diagnosis and treatment of primary aldosteronism -The Japan Endocrine Society 2009-
  • Task Force Committee on Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society 2009
  • Guidelines for the diagnosis and treatment of primary aldosteronism--the Japan Endocrine Society
  • Guidelines for the Diagnosis and Treatment of Primary Aldosteronism–the Japan Endocrine
  • Task Force Committee of Primary Aldosteronism, The Japan Endocrine Society. Guidelines for the diagnosis and treatment of primary aldosteronism-the Japan Endocrine Society 2009

この論文をさがす

抄録

The Japan Endocrine Society (JES) attempted to develop guidelines for the diagnosis and treatment of primary aldosteronism (PA). The Task Force Committee (TFC) was composed of a chair, selected by the JES, and additional experts. Systematic reviews of available evidence for Japanese patients were used to recommend the key treatment and prevention. We have evaluated the methods of screening, confirmatory tests and imaging, plus adrenal vein sampling (AVS). Consensus was guided by systematic review of evidence and discussion during each annual meeting of the JES, plus its related meetings, and by e-mail communication. The drafts prepared by TFC were reviewed successively by the members of Research on Intractable Diseases provided by the Japanese Ministry of Health, Labour and Welfare, and in comments from the JES’s councilors. At each stage of review, TFC received written comments and incorporated suggested changes. In conclusion, all patients with hypertension should be screened for PA, because of the high prevalence of cardiovascular disease and the current low case-detection rate in Japan. Case detection can be performed in hypertensive patients and those with hypokalemia by determining the aldosterone/renin ratio, and the diagnosis of PA can be confirmed by two of three confirmatory tests. The presence of a unilateral aldosterone-producing adenoma should be established/excluded by AVS by an experienced radiologist, optimally followed by laparoscopic adrenalectomy. In contrast, patients with bilateral adrenal hyperplasia, or those unsuitable for surgery, are optimally treated medically with mineralocorticoid receptor antagonists.

収録刊行物

  • Endocrine Journal

    Endocrine Journal 58 (9), 711-721, 2011

    一般社団法人 日本内分泌学会

被引用文献 (155)*注記

もっと見る

参考文献 (34)*注記

もっと見る

関連プロジェクト

もっと見る

詳細情報

問題の指摘

ページトップへ